SCHEMBL27168709

SCHEMBL27168709

CC(C)(C)c1c(CCN)c2ccccc2n1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IL1R1 P14778 1/20 0.46
▸ ALDH1A1 P00352 6/20 0.45
▸ MEN1 O00255 4/20 0.45
▸ KMT2A Q03164 4/20 0.45
▸ MAPT P10636 3/20 0.45
▸ HTT P42858 2/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ PLA2G2A P14555 2/20 0.40
▸ POLB P06746 1/20 0.39
▸ HTR6 P50406 1/20 0.38
▸ KDM4E B2RXH2 4/20 0.37
▸ EGFR P00533 2/20 0.37
▸ FOLH1 Q04609 1/20 0.37
▸ HPGD P15428 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ HTR2A P28223 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ GRIN1 Q05586 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27168761 0.79 MTNR1A (0.45) ALDH1A1
SCHEMBL16340215 0.75 POLB (0.44) ALDH1A1MEN1KMT2AMAPTHTT
SCHEMBL4024428 0.75 NPC1 (0.43) HTTL3MBTL1POLBKDM4EEGFR
SCHEMBL27721422 0.74 IL1R1 (0.47) IL1R1ALDH1A1MEN1KMT2AMAPT
SCHEMBL27935661 0.71 IL1R1 (0.44) IL1R1ALDH1A1MEN1KMT2AMAPT
SCHEMBL27700740 0.70 IL1R1 (0.43) IL1R1ALDH1A1MEN1KMT2AMAPT
SCHEMBL1258754 0.70 CTSL (0.45) ALDH1A1
SCHEMBL25292726 0.70 IL1R1 (0.42) IL1R1ALDH1A1MEN1KMT2AMAPT
SCHEMBL10824196 0.69 KMT2A (0.39) IL1R1ALDH1A1MEN1KMT2AMAPT
SCHEMBL9096837 0.69 CHRM2 (0.43) IL1R1ALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240226228-A1 ANTIMICROBIAL PEPTOID HAVING IMPROVED SELECTIVITY AND ANTIMICROBIAL COMPOSITION COMPRISING SAME GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2024-07-11 — — US disclosed
EP-4335861-A1 ANTIMICROBIAL PEPTOID HAVING IMPROVED SELECTIVITY AND ANTIMICROBIAL COMPOSITION COMPRISING SAME Gwangju Institute of Science and Technology (KR) 2024-03-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240226228-A1 ANTIMICROBIAL PEPTOID HAVING IMPROVED SELECTIVITY AND ANTIMICROBIAL COMPOSITION COMPRISING SAME NOD2, VIP, IDO1 IL1R1 3229/4885ALDH1A1 4812/4885MEN1 1046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback